Tuesday, November 18, 2014
Print Current Session:
|
|
Tuesday
SESSION 17:
NATURAL HISTORY, BEST MEDICAL TREATMENT, PREVENTION OF ARTERIOSCLEROSIS AND ITS COMPLICATIONS
Moderators:Bruce A. Perler, MD, MBA / Keith D. Calligaro, MD
|
|
SESSION 17 SCHEDULE | |
6:43 AM - 6:48 AM | Can Medical Treatment Slow The Growth Of Small AAAs |
Presenter(s):Frank A. Lederle, MD | |
View Abstract | |
6:49 AM - 6:54 AM | Are There New Medical Techniques For Limiting AAA Growth With Drugs (Telmisartan) And Cell Therapy: How Can They Work |
Presenter(s):Ronald L. Dalman, MD | |
View Abstract | |
6:55 AM - 7:00 AM | Are Statins Decreasing The AAA Rupture Rate: Results From A Danish Nationwide Population-Based Study |
Presenter(s):Jes S. Lindholt, MD | |
View Abstract | |
7:01 AM - 7:06 AM | A New Agent PCSK9 To Lower LDL: How Low Can LDL Go And Is It Safe |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
7:07 AM - 7:12 AM | What Is The Association Between The A/B Index And MI And Stroke Risk: Can It Be Altered; What Is The Association Between Obesity And Vascular Disease In Various Vascular Beds: When Is Being Fat Good |
Presenter(s):Caron B. Rockman, MD | |
View Abstract | |
7:13 AM - 7:18 AM | DEBATE: Statins Have No Role To Play In Primary Prevention And Should Be Avoided In Most Patients |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Abstract | |
7:19 AM - 7:24 AM | DEBATE: Nonsense: Statins Are A Game Changer, A Miracle Drug: They Should Be Used More Widely In Primary Prevention: Optimal Dosage Of Which Drug |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
7:25 AM - 7:30 AM | Statins In Vascular Patients: Are There Non-Responders And Responders – How To Tell And What To Do With Non-Responders: What To Do When Patients Have “Apparent Toxicity”: How To Load Preop And Preprocedurally |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
7:31 AM - 7:36 AM | Optimal Beta Blocker Management In Patients Requiring Vascular Surgery Or Intervention: Current Facts And Optimal Dosing And Drug |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS | |
View Abstract | |
7:35 AM - 7:45 AM | Panel Discussion |
END OF SESSION 17 | |
previous | next |